TORONTO–(BUSINESS WIRE)– #AlconCanada–Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY® Vitreoretinal Cataract System (VCS) has received Health Canada approval. This innovation is the first…
Author: Business Wire
La dernière technologie chirurgicale révolutionnaire d’Alcon, Unity VCS, reçoit l’approbation de Santé Canada
TORONTO–(BUSINESS WIRE)–Alcon, le chef de file mondial en matière de soins oculaires qui se consacre à aider les gens à voir avec clarté, a annoncé aujourd’hui que UNITY® Vitreoretinal Cataract System (VCS) a reçu l’approbation de Santé Canada. Cette…
Outcome Capital Launches the First Dedicated Ophthalmology Practice to Address the World’s Leading Cause of Disability
BOSTON–(BUSINESS WIRE)– #InvestmentBanking–Outcome Capital, LLC, today announced that Paul Ryb has been appointed Managing Director and will lead the firm’s dedicated ophthalmology practice.
FELIQS Appoints Gregory Kunst and Joe Zenkus to Board of Directors
FUKUOKA, Japan & NEW YORK–(BUSINESS WIRE)–FELIQS Corporation (“FELIQS”), a biotechnology company developing first-in-class small molecule therapeutics targeting oxidized lipids for rare pediatric retinal diseases, today announced the today announced …
ViaLase Announces Strategic Leadership Transitions to Support Commercial Growth
ALISO VIEJO, Calif.–(BUSINESS WIRE)– #POAG–ViaLase, Inc., a medical technology company pioneering noninvasive femtosecond laser treatments for glaucoma, today announced key changes to its executive leadership team as the company prepares for commerc…
Breakthrough in Ophthalmology! Hengrui’s Heng Qin® (Perfluorohexyloctane Eye Drops) Approved as First Treatment for Dry Eye Disease Associated with MGD
JIANGSU, China & HEIDELBERG, Germany & CAMBRIDGE, Mass.–(BUSINESS WIRE)– #EyeSol–Jiangsu Hengrui Pharmaceuticals Co., Ltd. (“Hengrui Pharma”), a global pharmaceutical company focused on scientific and technological innovation, and Novaliq GmbH (“Nov…
Inverness Graham-backed Innovia Medical Completes Two Strategic Acquisitions, Establishes Leading Manufacturer of ENT and Ophthalmic Surgical Products
WAYNE, Pa.–(BUSINESS WIRE)–Inverness Graham, a Philadelphia-based buyout firm focused on acquiring innovative companies where technology is transforming traditional industry, announced today that its single-use surgical products manufacturer, Innovia…
Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)
GENEVA–(BUSINESS WIRE)–Alcon to Acquire LumiThera and its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)
Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the C…
Innovia Medical Advances Strategic Vision with Acquisitions of Grace Medical and Hurricane Medical
ST. PAUL, Minn.–(BUSINESS WIRE)–Innovia Medical, a global medical device company focused on specialty surgical products, announced today the acquisitions of two well-respected specialty medical device companies: Grace Medical, a global leader in Ear,…
Despite Majority of Americans Struggling with the Impact of Poor Eyesight and Eye Health on Daily Life, More than Half Are Delaying or Avoiding Eye Care
NEW YORK–(BUSINESS WIRE)– #EyeCare–New Versant Health study finds 86% of Americans would seek eye exams if linked to overall health. Education, access and tech drive vision benefit use.
FELIQS announces $9 Million Series A Financing to Advance FLQ-101 Clinical Program for Retinopathy of Prematurity
FUKUOKA, Japan & NEW YORK–(BUSINESS WIRE)–FELIQS Corporation (“FELIQS”), a biotechnology company developing first-in-class small molecule therapeutics targeting oxidized lipids for rare pediatric retinal diseases, today announced the successful compl…
Bausch + Lomb Combines Patient Voices and New Survey Insights to Combat Persistent Misconceptions about Dry Eye
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today launched “Eyes Tell the Story: The Impact of Dry Eye.” The campaign aims to …
Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter financial results on Wednesday, July 30, 2025. The…
Age-Related Vision Dysfunction Market Analysis and Forecasts, 2025-2035 | Geriatric Boom Fuels Demand for Effective Vision Correction Solutions Globally – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Age-Related Vision Dysfunction Market – A Global and Regional Analysis: Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. Global age-related vision dysfunction (ARVD) market is o…
Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today announced that its subsidiaries, Bausch+L…
Alcon Canada Earns Global Recognition as a Top Employer
TORONTO–(BUSINESS WIRE)– #AlconCanada–Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that Alcon Canada has been certified as a Top Employer in Canada by the Top Employers Institute, a recognized aut…
Alcon Canada reçoit une reconnaissance mondiale comme l’un des meilleurs employeurs
TORONTO–(BUSINESS WIRE)–Alcon, le chef de file mondial en soins oculaires qui se consacre à aider les gens à voir avec clarté, a annoncé aujourd’hui qu’Alcon Canada a reçu la certification de meilleur employeur au Canada décernée par le Top Employers…
GenSight Biologics Announces Significant Milestone in New Manufacturing Partnership with Catalent
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
GenSight Biologics annonce une avancée majeure dans son nouveau partenariat de fabrication avec Catalent
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible au PEA-PME), société biopharmaceutique spécialisée dans le développement et la commercialisation de thérapies géniques innovantes pour les mala…